Global Cancer Immunotherapy Market Size, Status and Forecast 2022

Published: Nov, 2017 | Pages: 99 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)

This report studies the global Cancer Immunotherapy market, analyzes and researches the Cancer Immunotherapy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Amgen, Inc.
    AstraZeneca
    F. Hoffmann La Roche Ltd.
    Bayer AG
    Bristol-Myers Squibb Company
    Eli Lilly and Company
    Merck and Co., Inc.
    Novartis AG
    Pfizer, Inc.

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Monoclonal Antibodies
    Immunomodulators
    Oncolytic Viral Therapies and Cancer Vaccines

Market segment by Application, Cancer Immunotherapy can be split into
    Lung Cancer
    Breast Cancer
    Colorectal Cancer
    Melanoma
    Prostate Cancer
    Head and Neck Cancer
    Ovarian Cancer
    Pancreatic Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Global Cancer Immunotherapy Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Immunotherapy
    1.1  Cancer Immunotherapy Market Overview
        1.1.1 Cancer Immunotherapy Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Cancer Immunotherapy Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Cancer Immunotherapy Market by Type
        1.3.1 Monoclonal Antibodies
        1.3.2 Immunomodulators
        1.3.3 Oncolytic Viral Therapies and Cancer Vaccines
    1.4 Cancer Immunotherapy Market by End Users/Application
        1.4.1 Lung Cancer
        1.4.2 Breast Cancer
        1.4.3 Colorectal Cancer
        1.4.4 Melanoma
        1.4.5 Prostate Cancer
        1.4.6 Head and Neck Cancer
        1.4.7 Ovarian Cancer
        1.4.8 Pancreatic Cancer

2 Global Cancer Immunotherapy Competition Analysis by Players
    2.1 Cancer Immunotherapy Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Amgen, Inc.
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 AstraZeneca
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 F. Hoffmann La Roche Ltd.
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Bayer AG
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Bristol-Myers Squibb Company
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Eli Lilly and Company
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Merck and Co., Inc.
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Novartis AG
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Pfizer, Inc.
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Cancer Immunotherapy Revenue (Value) (2012-2017)
        3.9.5 Recent Developments

4 Global Cancer Immunotherapy Market Size by Type and Application (2012-2017)
    4.1 Global Cancer Immunotherapy Market Size by Type (2012-2017)
    4.2 Global Cancer Immunotherapy Market Size by Application (2012-2017)
    4.3 Potential Application of Cancer Immunotherapy in Future
    4.4 Top Consumer/End Users of Cancer Immunotherapy

5 United States Cancer Immunotherapy Development Status and Outlook
    5.1 United States Cancer Immunotherapy Market Size (2012-2017)
    5.2 United States Cancer Immunotherapy Market Size and Market Share by Players (2016 and 2017)

6 EU Cancer Immunotherapy Development Status and Outlook
    6.1 EU Cancer Immunotherapy Market Size (2012-2017)
    6.2 EU Cancer Immunotherapy Market Size and Market Share by Players (2016 and 2017)

7 Japan Cancer Immunotherapy Development Status and Outlook
    7.1 Japan Cancer Immunotherapy Market Size (2012-2017)
    7.2 Japan Cancer Immunotherapy Market Size and Market Share by Players (2016 and 2017)

8 China Cancer Immunotherapy Development Status and Outlook
    8.1 China Cancer Immunotherapy Market Size (2012-2017)
    8.2 China Cancer Immunotherapy Market Size and Market Share by Players (2016 and 2017)

9 India Cancer Immunotherapy Development Status and Outlook
    9.1 India Cancer Immunotherapy Market Size (2012-2017)
    9.2 India Cancer Immunotherapy Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Cancer Immunotherapy Development Status and Outlook
    10.1 Southeast Asia Cancer Immunotherapy Market Size (2012-2017)
    10.2 Southeast Asia Cancer Immunotherapy Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Cancer Immunotherapy Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
        11.1.2 EU Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
        11.1.4 China Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
        11.1.5 India Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Cancer Immunotherapy Revenue and Growth Rate (2017-2022)
    11.2 Global Cancer Immunotherapy Market Size (Value) by Type (2017-2022)
    11.3 Global Cancer Immunotherapy Market Size by Application (2017-2022)

12 Cancer Immunotherapy Market Dynamics
    12.1 Cancer Immunotherapy Market Opportunities
    12.2 Cancer Immunotherapy Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Cancer Immunotherapy Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Cancer Immunotherapy Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures

    Figure Cancer Immunotherapy Product Scope
    Figure Global Cancer Immunotherapy Market Size (Million USD) (2012-2017)
    Table Global Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Cancer Immunotherapy Market Share by Regions in 2016
    Figure United States Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure EU Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Japan Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure China Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure India Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Southeast Asia Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Figure Global Cancer Immunotherapy Market Share by Type in 2016
    Figure Monoclonal Antibodies Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Immunomodulators Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Oncolytic Viral Therapies and Cancer Vaccines Market Size (Million USD) and Growth Rate (2012-2017)
    Figure Global Cancer Immunotherapy Market Share by Application in 2016
    Table Key Downstream Customer in Lung Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Lung Cancer (2012-2017)
    Table Key Downstream Customer in Breast Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Breast Cancer (2012-2017)
    Table Key Downstream Customer in Colorectal Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Colorectal Cancer (2012-2017)
    Table Key Downstream Customer in Melanoma
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Melanoma (2012-2017)
    Table Key Downstream Customer in Prostate Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Prostate Cancer (2012-2017)
    Table Key Downstream Customer in Head and Neck Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Head and Neck Cancer (2012-2017)
    Table Key Downstream Customer in Ovarian Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Ovarian Cancer (2012-2017)
    Table Key Downstream Customer in Pancreatic Cancer
    Figure Cancer Immunotherapy Market Size (Million USD) and Growth Rate in Pancreatic Cancer (2012-2017)
    Table Cancer Immunotherapy Market Size (Million USD) by Players (2016 and 2017)
    Figure Cancer Immunotherapy Market Size Share by Players in 2016
    Figure Cancer Immunotherapy Market Size Share by Players in 2017
    Table Amgen, Inc. Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Amgen, Inc. (2012-2017)
    Figure Amgen, Inc. Cancer Immunotherapy Business Revenue Market Share in 2016
    Table AstraZeneca Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of AstraZeneca (2012-2017)
    Figure AstraZeneca Cancer Immunotherapy Business Revenue Market Share in 2016
    Table F. Hoffmann La Roche Ltd. Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of F. Hoffmann La Roche Ltd. (2012-2017)
    Figure F. Hoffmann La Roche Ltd. Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Bayer AG Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Bayer AG (2012-2017)
    Figure Bayer AG Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Bristol-Myers Squibb Company Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
    Figure Bristol-Myers Squibb Company Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Eli Lilly and Company Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Eli Lilly and Company (2012-2017)
    Figure Eli Lilly and Company Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Merck and Co., Inc. Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Merck and Co., Inc. (2012-2017)
    Figure Merck and Co., Inc. Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Novartis AG Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Novartis AG (2012-2017)
    Figure Novartis AG Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Pfizer, Inc. Basic Information List
    Table Cancer Immunotherapy Business Revenue (Million USD) of Pfizer, Inc. (2012-2017)
    Figure Pfizer, Inc. Cancer Immunotherapy Business Revenue Market Share in 2016
    Table Global Cancer Immunotherapy Market Size (Million USD) by Type (2012-2017)
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2012
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2013
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2014
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2015
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2016
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2017
    Table Global Cancer Immunotherapy Market Size (Million USD) by Application (2012-2017)
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2012
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2013
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2014
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2015
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2016
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2017
    Table Top Consumer/End Users of Cancer Immunotherapy
    Figure United States Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table United States Cancer Immunotherapy Market Size (Million USD) by Players (2012-2017)
    Figure United States Cancer Immunotherapy Market Size Share by Players in 2016
    Figure United States Cancer Immunotherapy Market Size Share by Players in 2017
    Figure EU Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table EU Cancer Immunotherapy Market Size (Million USD) by Players (2012-2017)
    Figure EU Cancer Immunotherapy Market Size Share by Players in 2016
    Figure EU Cancer Immunotherapy Market Size Share by Players in 2017
    Figure Japan Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Japan Cancer Immunotherapy Market Size (Million USD) by Players (2012-2017)
    Figure Japan Cancer Immunotherapy Market Size Share by Players in 2016
    Figure Japan Cancer Immunotherapy Market Size Share by Players in 2017
    Figure China Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table China Cancer Immunotherapy Market Size (Million USD) by Players (2012-2017)
    Figure China Cancer Immunotherapy Market Size Share by Players in 2016
    Figure China Cancer Immunotherapy Market Size Share by Players in 2017
    Figure India Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table India Cancer Immunotherapy Market Size (Million USD) by Players (2012-2017)
    Figure India Cancer Immunotherapy Market Size Share by Players in 2016
    Figure India Cancer Immunotherapy Market Size Share by Players in 2017
    Figure Southeast Asia Cancer Immunotherapy Market Size (Million USD) and Growth Rate by Regions (2012-2017)
    Table Southeast Asia Cancer Immunotherapy Market Size (Million USD) by Players (2012-2017)
    Figure Southeast Asia Cancer Immunotherapy Market Size Share by Players in 2016
    Figure Southeast Asia Cancer Immunotherapy Market Size Share by Players in 2017
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Regions (2017-2022)
    Table Global Cancer Immunotherapy Market Size (Million USD) by Regions (2017-2022)
    Figure Global Cancer Immunotherapy Market Size Share by Regions in 2017
    Figure Global Cancer Immunotherapy Market Size Share by Regions in 2022
    Figure United States Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure EU Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Japan Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure China Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure India Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2017-2022)
    Figure Southeast Asia Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2017-2022)
    Table Global Cancer Immunotherapy Market Size (Million USD) by Type (2017-2022)
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2017
    Figure Global Cancer Immunotherapy Market Size Share by Type in 2022
    Table Global Cancer Immunotherapy Market Size (Million USD) by Application (2017-2022)
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2017
    Figure Global Cancer Immunotherapy Market Size (Million USD) by Application in 2022